SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001140361-18-018573
Filing Date
2018-04-13
Accepted
2018-04-13 17:28:01
Documents
1
Period of Report
2018-04-11

Document Format Files

Seq Description Document Type Size
1 FORM 4 doc1.html 4  
1 FORM 4 doc1.xml 4 1700
  Complete submission text file 0001140361-18-018573.txt   3228
Mailing Address 100-8900 GLENLYON PARKWAY BURNABY A1 V5J 5J8
Business Address 100-8900 GLENLYON PARKWAY BURNABY A1 V5J 5J8 604-419-3200
Arbutus Biopharma Corp (Issuer) CIK: 0001447028 (see all company filings)

IRS No.: 980597776 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ARBUTUS BIOPHARMA CORP. 100-8800 GLENLYON PARKWAY BURNABY A1 V5J 5J8
Business Address
Lutwyche Peter (Reporting) CIK: 0001628358 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-34949 | Film No.: 18755103